Health
Results: 541-552 of 10105

Chiesi Advances Its Carbon Minimal Inhaler Journey as European Submissions for Its Single Inhaler Triple Therapy (SITT) and ICS/LABA Combination Next-Generation Propellant pMDIs Are Validated

Lundbeck to highlight mechanistic insights on bexicaserin's dual mode of action at the European Epilepsy Congress







